Skip to content
Recall Observatory FDA recall evidence

Drug product

Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.

D-0926-2017

June 12, 2017

Class III

Product summary

Firm
Sanofi-Aventis U.S. LLC
Event
Event 77478
Status
Terminated
Classification
Class III
Quantity
2980 bottles
Official record key
drug-enforcement:D-0926-2017

Official wording

Reason: Superpotent Drug: high out-of-specification result for magnesium.

Code information: Lot #: 5J69A, Exp 02/19; 6GF2A, 6GF3A, Exp 08/19

Distribution pattern: Nationwide in the USA, Puerto Rico, and the United Kingdom.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent

Field note

Send feedback

We'll only use this to respond to your feedback.